Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) announced preclinical safety data for Nu-3, a gel formulation targeting the topical treatment of infected ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE